India · Delayed Price · Currency is INR Marinus Pharmaceuticals Statistics
Total Valuation
BOM:532508 has a market cap or net worth of INR 562.88 billion. The enterprise value is 604.36 billion.
| Market Cap | 562.88B |
| Enterprise Value | 604.36B |
Important Dates
The last earnings date was Friday, July 25, 2025.
| Earnings Date | Jul 25, 2025 |
| Ex-Dividend Date | Aug 22, 2025 |
Share Statistics
| Current Share Class | 823.65M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 353.99M |
Valuation Ratios
The trailing PE ratio is 21.89 and the forward PE ratio is 17.53.
| PE Ratio | 21.89 |
| Forward PE | 17.53 |
| PS Ratio | 1.40 |
| PB Ratio | 3.37 |
| P/TBV Ratio | 3.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 23.50 |
| EV / Sales | 1.51 |
| EV / EBITDA | 12.80 |
| EV / EBIT | 16.19 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.38 |
| Debt / EBITDA | 1.34 |
| Debt / FCF | n/a |
| Interest Coverage | 6.18 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 10.88% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 76.33M |
| Profits Per Employee | 4.90M |
| Employee Count | 5,252 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:532508 has paid 8.54 billion in taxes.
| Income Tax | 8.54B |
| Effective Tax Rate | 24.95% |
Stock Price Statistics
The stock price has increased by +7.04% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +7.04% |
| 50-Day Moving Average | 688.98 |
| 200-Day Moving Average | 654.73 |
| Relative Strength Index (RSI) | 46.85 |
| Average Volume (20 Days) | 40,220 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:532508 had revenue of INR 400.90 billion and earned 25.71 billion in profits. Earnings per share was 31.21.
| Revenue | 400.90B |
| Gross Profit | 83.17B |
| Operating Income | 37.89B |
| Pretax Income | 34.22B |
| Net Income | 25.71B |
| EBITDA | 47.76B |
| EBIT | 37.89B |
| Earnings Per Share (EPS) | 31.21 |
Balance Sheet
The company has 22.74 billion in cash and 64.02 billion in debt, giving a net cash position of -41.28 billion.
| Cash & Cash Equivalents | 22.74B |
| Total Debt | 64.02B |
| Net Cash | -41.28B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 167.08B |
| Book Value Per Share | 202.74 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 20.75%, with operating and profit margins of 9.45% and 6.41%.
| Gross Margin | 20.75% |
| Operating Margin | 9.45% |
| Pretax Margin | 8.54% |
| Profit Margin | 6.41% |
| EBITDA Margin | 11.91% |
| EBIT Margin | 9.45% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 3.00, which amounts to a dividend yield of 0.41%.
| Dividend Per Share | 3.00 |
| Dividend Yield | 0.41% |
| Dividend Growth (YoY) | 50.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.01% |
| Shareholder Yield | 0.41% |
| Earnings Yield | 4.57% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |